Vitamin B 6 (B 6 ) deficiency affects homocysteine metabolism, and this leads to hyperhomocysteinemia. In this study, we examined i) the effects of B 6 -deficiency and graduated levels of dietary methionine on homocysteine metabolism, and ii) the effects of fortified folate on homocysteine metabolism. In experiment 1, Wistar male rats were fed a control or a B 6 -deficient diet supplemented with L-methionine at a level of 3, 6, or 9 g/kg of diet for 5 weeks. The resulting plasma homocysteine levels in the B 6 -deficient groups increased in relation to the increase in dietary methionine level. Next, in experiment 2, rats were fed a control, B 6 -deficient, or folate enriched (10 mg pteroylmonoglutamic acid/kg) B 6 -deficient diet containing L-methionine at 9 g/kg for 5 weeks. Although the B 6 -deficient diet induced hyperhomocysteinemia, folate fortification ameliorated the plasma homocysteine concentration. Overall, our results indicate that folate fortification ameliorates the hyperhomocysteinemia induced by B 6 deficiency and supplemental methionine intake.
Homocysteine (Hcy) is a metabolic intermediate of methionine, an essential amino acid (Fig. 1) . Epidemiologically, an elevated plasma concentration of Hcy is an independent risk factor for cardiovascular disease and atherosclerosis, [1] [2] [3] and hence it is important to reduce Hcy formation or to increase its removal via metabolism. Homocysteine has two metabolic pathways. In the trans-sulfuration pathway, Hcy is metabolized to cysteine by cystathionine -synthase (EC 4.2.1.22; CBS) and cystathionine -lyase (EC 4.4.1.1; CGL). These two enzymes require pyridoxal 5 0 -phosphate (PLP) as coenzyme. The second pathway is called the remethylation pathway. In it, folate and vitamin B 12 (B 12 ) or betaine is required. Thus three B-group vitamins are involved in the metabolism of Hcy, and deficiencies in the respective vitamins have been reported to cause hyperhomocysteinemia. [4] [5] [6] [7] [8] In addition, dietary methionine content is reported to be another parameter in hyperhomocysteinemia. 9) We have reported that vitamin B 6 (B 6 ) deficiency in a 70% casein diet did not always cause severe hyperhomocysteinemia in rats. 4) Thus the way methionine levels affect Hcy levels, under B 6 -deficient conditions is an issue of concern. The involvement of the three B-group vitamins in Hcy metabolism led us to speculate that additional dietary folate should contribute toward improving hyperhomocysteinemia under B 6 -deficient dietary conditions.
To test this hypothesis, we planned two experiments. In experiment 1, the effect of B 6 -deficiency with a graduated level of dietary methionine on methionine metabolism, including Hcy, was examined. In experiment 2, the effect of supplemental folate on hyperhomocysteinemia caused by B 6 -deficiency was examined. In the latter experiment, we also undertook a pilot study of the way folate relieves a deficiency of B 6 in cooperatively operating metabolic pathways.
Materials and Methods
Animals. This study was approved by the Committee for Animal Research and Welfare of Gifu University on the Proper Use of Laboratory Animals. Male 4-week-old Wistar rats weighing 80-100 g were obtained from Japan SLC (Hamamatsu, Japan). The rats were housed individually in stainless-steel wire-bottomed cages in an animal room at 23 AE 1 C on an inverted 12 h light-dark cycle (lights on at BHMT, betaine-homocysteine S-methyltransferase; CBS, cystathionine -synthase; CGL, cystathionine -lyase; 5,10-CH 2 -THF, 5,10-methylenetetrahydrofolate; DHF, dihydrofolate; MS, methionine synthase; 5-MTHF, 5-methyltetrahydrofolate; PteGlu, pteroylmonoglutamic acid; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine; THF, tetrahydrofolate; X, methyl groupacceptor.
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Diets and experimental procedures. Two separate experiments were conducted. In experiment 1, the rats were randomly divided into six groups (n ¼ 6 each) fed either an AIN-76 diet-based control diet (C) or a B 6 -deficient diet (D) supplemented with graduated levels of Lmethionine. The experimental diet compositions are shown in Table 1 . Control diets supplemented with L-methionine at levels of 3, 6, and 9 g/kg of diet were designated C3, C6, and C9 respectively, and B 6 -deficient diets supplemented with the same graduated levels of Lmethionine were designated D3, D6, and D9 respectively. The D9 group had free access to the D9 diet, and the other groups were pair-fed to the D9 group. Body weight was measured daily at about 0900 h. At 0900 h on the final morning of the feeding period, the rats were anesthetized with diethyl ether, and blood was collected via the abdominal aorta with a heparinized syringe. The livers were immediately excised, rinsed in ice-cold 0.25 M sucrose, blotted on paper towels, weighed, quickly frozen in liquid nitrogen, and stored at À20 C until analyzed. In experiment 2, the rats were randomly divided into three groups (n ¼ 6 each) that were fed one of the following diets supplemented with L-methionine at 9 g/kg of diet: an AIN-76 based control diet (C9), a B 6 -deficient diet (D9), and a folate enriched (10 mg pteroylmonoglutamic acid/kg) B 6 -deficient diet (F9). This experiment was conducted under the same protocol as experiment 1. In both experiments, plasma was obtained from heparinized whole blood by centrifugation at 2;000 Â g (4 C) for 15 min. The plasma and liver were stored at À20 C until analyzed.
Materials. S-Adenosylhomocysteine (SAH), S-adenosylmethionine (SAM), and cysteamine hydrochloride were purchased from SigmaAldrich (St. Louis, MO). 4-Fluoro-7-sulfobenzofurazan ammonium salt (SBD-F), 1-heptanesulfonic acid sodium salt, and pyridoxamine 5 0 -phosphate (PMP) were from Wako Pure Chemical Industries (Osaka, Japan). Methanol and acetonitrile (HPLC grade) were from Kanto Chemical (Tokyo). The other reagents were purchased from Nacalai Tesque (Kyoto, Japan), unless otherwise indicated.
Analysis of vitamin B 6 in plasma and liver. Plasma PLP, liver PLP, PMP, and pyridoxal (PL) levels were determined by isocratic HPLC with fluorescence detection (PLP: Ex. 320 nm; Em. 420 nm, PMP and PL: Ex. 305 nm; Em. 390 nm) by the method of Tsuge.
10)
Measurement of plasma Hcy and cysteine. Plasma total Hcy was measured by the method of Yamaguchi et al., 11) which uses an isocratic HPLC system equipped with a fluorescence detector (Ex. 380 nm; Em. 525 nm). In experiment 2, plasma cysteine was measured by the same method.
Measurement of SAM and SAH in liver. Hepatic SAM and SAH levels were measured by the method of She et al.
12) using isocratic HPLC with ultraviolet detection (254 nm). 
Results

Experiment 1 Growth parameters
Final body weight and total food intake did not differ among the six experimental groups. However, the whole liver weight in the D9 group was significantly higher than in the other groups (Table 2) .
Vitamin B 6 status Plasma PLP was significantly lower in the three vitamin B 6 -deficient diet groups, and the dietary methionine level did not affect plasma PLP levels ( Table 2 ). Both liver PLP and liver PMP levels were also significantly lower in the B 6 -deficient diet groups. The reduction in B 6 in the liver was not as severe as in the plasma.
Methionine metabolites in the plasma and liver Plasma Hcy showed a significant increase only with the D9 group (Fig. 2) . In the control groups, increased dietary methionine levels did not affect the plasma Hcy concentration. In contrast, the plasma Hcy levels in the B 6 -deficient groups increased as the dietary methionine level increased, and a significant increase in Hcy, was observed for the D9 group. The hepatic SAM concentration was not affected by the dietary methionine level or B 6 deficiency, but the hepatic SAH concentration in the D9 group showed a significant increase ( Table 2) . 1 Control diets supplemented with 3 (C3), 6 (C6), 9 (C9) g of L-methionine per kg of diet.
2 Vitamin B 6 -deficient diets supplemented with 3 (D3), 6 (D6), 9 (D9) g of L-methionine per kg of diet.
3 Folate-enriched B 6 -deficient diet supplemented with 9 (F9) g of L-methionine per kg of diet. 4 The content of folic acid in this vitamin mixture was 100 mg/100 g, 5 times higher than the AIN-76 vitamin mixture.
Experiment 2 Growth parameters
Final body weight and total food intake did not differ among the three experimental groups. The liver weight in the D9 group was significantly higher than in the C9 group (Table 3) .
Vitamin B 6 status Plasma PLP significantly decreased with B 6 deprivation (Table 3) , and the concentrations of PLP and total B 6 in the livers of the B 6 -deficient rats were also significantly lower than those of the control rats (Fig. 3) . Plasma and liver PLP levels were not affected by folate fortification, but liver PMP, PL, and total B 6 were significantly higher in the folate enriched group.
Modification of methionine metabolism by folate fortification
Although the B 6 -deficient diet induced hyperhomocysteinemia in the D9 group, folate fortification (F9 group) ameliorated this condition (Fig. 4A) . In contrast, the plasma cysteine concentration was lower in the D9 group, and improved in the F9 group (Fig. 4B) . Similarly to plasma Hcy, the hepatic SAH concentration increased significantly in the D9 group and was significantly lower in the F9 group (Table 3) . There was no significant difference in the amount of SAM in the liver for these groups.
Discussion
Vitamin B 6 (PLP) is a cofactor of CBS, which catalyzes the conversion of Hcy to cysteine. Smolin et al. have reported that B 6 deficiency reduced CBS activity and induced hyperhomocysteinemia. 13) Referring to earlier experiments, She et al. reported that CBS activity was significantly decreased by B 6 deficiency, 14) Each value is the mean AE SE (n ¼ 6). For the experimental groups, see the legend to Table 1 . Means not sharing the same superscript are significantly different at p < 0:05 as determined by one-way ANOVA followed by Tukey's multiple comparison test. Each value is mean AE SE (n ¼ 6). For the experimental groups, see the legends to Table 1 .
Means not sharing the same superscript are significantly different at p < 0:05 as determined by one-way ANOVA followed by Tukey's multiple comparison test.
which is indicative of its involvement in Hcy homeostasis. It has also been reported that the liver Hcy content was increased by B 6 -deficiency. 5) In fact, CBS deficiency has been reported to induce severe hyperhomocysteinemia in humans 15) and mice. 16 ) So, B 6 -deficient dietary conditions tend to cause hyperhomocysteinemia via lowered metabolism of Hcy to cysteine, but we observed that hyperhomocysteinemia was not induced by B 6 deficiency alone, and that concomitant methionine loading was necessary to elicit hyperhomocysteinemia under our dietary conditions (Fig. 2) . In this study, we found that 9 g/kg of methionine supplementation caused severe hyperhomocysteinemia in B 6 -deficient rats. According to recent reports, 17, 18) plasma homocysteine levels increase in response to the methionine intake level, and a dietary methionine loading of about 2% is likely to trigger severe hyperhomocysteinemia in rats. 17, 19) In the present study, B 6 -deficiency was regarded as the main cause of severe hyperhomocysteinemia, since methionine supplementation alone did not cause hyperhomocysteinemia (Fig. 2) . Thus B 6 -deficiency and methionine supplementation functioned synergistically to cause an accumulation of Hcy in the plasma. Although CBS activity was decreased by B 6 deficiency, it held at a sufficient level to metabolize homocysteine with moderate methionine supplementation. However, with high methionine supplementation, Hcy formation should outstrip Hcy metabolism by both the trans-sulfuration and the re-methylation pathway, leading to increased plasma homocysteine levels and accumulation.
We also observed SAH accumulation in the livers of the B 6 -deficient rats (Table 2) , similarly to the results obtained in previous studies. 4, 20) Isa et al. found that the accumulation of SAH was due to the increased SAH synthetic activity of SAH hydrolase, due to Hcy accumulation caused by B 6 deficiency. 4) Amelioration of hyperhomocysteinemia by folate fortification has also been observed in murine and human studies, 21, 22) but with only a small effect, but there have been no reports to the effect that folate fortification can reduce plasma Hcy concentrations elevated by B 6 deficiency. Thus this study is the first to indicate that hyperhomocysteinemia caused by B 6 deficiency can be improved by folate fortification.
In this study, folate fortification suppressed the increase in the plasma Hcy concentration (Fig. 4A) . In other studied, plasma Hcy in rats was increased by B 12 -deficiency, 7) methionine supplementation, 19) or choline-deficiency, 23) and was reduced by folate fortification. Since 5-methyltetrahydrofolate, a substrate for methionine synthase, imparts a methyl group to Hcy, 24) an increased supply of folate might promote the remethylation of Hcy by increasing the levels of 5-methyltetrahydrofolate. Considering that the formation of 5-methyltetrahydrofolate is catalyzed mainly by methylenetetrahydrofolate reductase (EC 1.5.1.20) and that its polymorphism relates to increased plasma Hcy, 25) 5-methyltetrahydrofolate may be a limiting substance in the re-methylation pathway. Hence we speculate that 5-methyltetrahydrofolate is more efficient than folate. In any case, it should be clarified how folate fortification increases 5-methyltetrahydrofolate levels in the liver.
The plasma cysteine concentration decreased in the D9 group, and it appeared to be influenced by CBS activity, which had been reduced by B 6 -deficiency (Fig. 4B ). Improvement in plasma cysteine level, in the F9 group might have resulted from a slight increase in liver B 6 due to folate fortification, although we have no idea how folate fortification affected liver B 6 levels.
Currently no report has indicated that hyperhomocysteinemia induced by B 6 -deficiency is ameliorated by folic acid supplementation. Since both B 6 and folate are involved in Hcy metabolism, the plasma Hcy level must be affected by the nutritional levels of both vitamins. This suggests that Hcy metabolism is affected not only Each value is the mean AE SE (n ¼ 6). For the experimental groups, see the legend to Table 1 . Means not sharing the same superscript are significantly different at p < 0:05 as determined by one-way ANOVA followed by Tukey's multiple comparison test. Each value is the mean AE SE (n ¼ 6). For the experimental groups, see the legend to Table 1 . Means not sharing the same superscript are significantly different at p < 0:05 as determined by one-way ANOVA followed by Tukey's multiple comparison test.
by the relevant vitamins (e.g., B 6 ) but also by related vitamins (e.g., folate). Further studies are needed to explore the involvement of these vitamins in regulation of the plasma Hcy concentration.
In summary, we found that supplementation of a B 6 -deficient diet with methionine induced a significant elevation in the plasma homocysteine concentration. We also found evidence that fortification by folate effectively ameliorates the hyperhomocysteinemia caused by B 6 -deficient and high dietary methionine conditions.
